Georgia Cannabis Advertising Laws

Georgia prohibits licensees from advertising or marketing low THC oil or products to registered patients or to the public. The one authorised route is providing information regarding a licensee's low THC oil and products directly to physicians. Georgia sets no audience composition percentage, requires no warning statement in advertising, and states no advertising buffer.

Working with a partner that already knows these rules shortens the launch cycle. See how we run campaigns as a cannabis marketing agency in Georgia.

Under O.C.G.A. §16-12-215(b), no licensee shall advertise or market low THC oil or products to registered patients or the public. The provision authorises a licensee to provide information regarding its low THC oil and products directly to physicians.

Georgia has no adult-use programme. It operates a low THC oil programme under the Hope Act, codified in Article 9 of Chapter 12 of Title 16, permitting licensed production and dispensing of low THC oil to registered patients. Possession of any other form of marijuana remains unlawful under state law.

The regulator is the Georgia Access to Medical Cannabis Commission, with dispensing also involving the State Board of Pharmacy. The operative advertising provision is O.C.G.A. §16-12-215(b). The Commission's rules at Chapter 351-6 implement it, principally Rule 351-6-.07, Advertising and Marketing.

There is one advertising rule set. Georgia does not run a separate adult-use or conventional medical framework alongside the low THC oil programme.

This page is part of our state-by-state cannabis advertising laws library, covering all 50 states and the District of Columbia.

The prohibition, in full

Under O.C.G.A. §16-12-215(b): "No licensee shall advertise or market low THC oil or products to registered patients or the public; provided, however, that a licensee shall be authorized to provide information regarding its low THC oil and products directly to physicians."

The provision names registered patients as well as the public.

The authorised route

Under Rule 351-6-.07(3), a dispensing licensee may provide information regarding product in final packaged form directly to physicians via electronic communication, printed mail pieces, or in-person communication. Those three methods are named in the rule. Under Rule 351-6-.07(1), information regarding product dispensed to patients shall be accurate, truthful, and appropriately substantiated as permissible by Commission rules.

Business name and licence number

Not required in advertising. Under Rule 351-6-.02(1)(a), the dispensing licence must be prominently displayed on the premises.

The required warning statements

None for advertising. Georgia requires cautionary statements or symbols on labelling as the Commission may require, which is a labelling duty.

How the warnings have to appear

Not applicable, as none are required in advertising.

When the warnings are not required

Not applicable. Section 16-12-215 contains no advertising disclosure requirement to disapply.

Hotline number

No. Georgia requires no helpline, hotline or poison control number.

Prohibited content and practices

Under Rule 351-6-.05(9), a dispensing licensee shall not:

• Use the Commission's name or logo on any sign at the premises, on the business's website, or in any advertising or social media, except to the extent the name or logo appears on the proof of licensure or is incorporated into warnings, signage, or other documents required by the rules — 351-6-.05(9)(b)
• Accept, store, or dispense product not in final packaged form
• Sublet any portion of the dispensary
• Provide samples of or free products to any person — 351-6-.05(9)(d)
• Allow products to be administered, applied, ingested, or consumed on the premises
• Offer tours of restricted access areas to the general public
• Display product in final packaged form in windows or in public view — 351-6-.05(9)(g)

Required premises signage

Under Rule 351-6-.02(1), a dispensing licensee shall prominently display on the premises the dispensing licence issued by the Commission, hours of operation, and a sign stating "No products can be administered, applied, ingested, or consumed on the premises" or a similar sign.

Packaging approval

Under Rule 351-6-.06, exit packaging must be reviewed and approved by the GMCC Executive Director, may use only trademarks, licensed logos, or imagery previously approved by the Commission or the Executive Director, and must be plain-coloured, light-resistant, and opaque.

Discounts, coupons, and price promotion

Section 16-12-215(b) prohibits advertising or marketing to registered patients or the public, so no consumer price advertising is permitted. Under Rule 351-6-.05(9)(d), a dispensing licensee shall not provide samples of or free products to any person.

What the Law Requires

Section 16-12-215(b) contains no age threshold and no audience composition test. It prohibits advertising or marketing to registered patients and to the public alike. Physicians are the one audience the provision authorises.

Georgia's Low THC Oil Registry includes patients under 18, who are registered through a caregiver.

Audience Percentage Thresholds

Section 16-12-215 sets no audience composition percentage. This is an absence in the statute rather than an omission from this page. Other states do set one: Connecticut requires reliable evidence that at least 90 percent of the audience is 21 or older, and Delaware requires at least 85 percent. Georgia states no equivalent figure.

Section 16-12-215(b) is framed as a prohibition on advertising to registered patients or the public rather than as a condition on audience composition.

Event sponsorship

Section 16-12-215 and Chapter 351-6 set no audience threshold specific to event sponsorship.

Where the burden sits

On the licensee. Section 16-12-215(b) places the prohibition and the physician authorisation on the licensee. Rule 351-6-.07(1) requires information regarding product dispensed to patients to be accurate, truthful, and appropriately substantiated.

Age Gating and Consent

Websites

Chapter 351-6 prescribes no website age gate.

Direct communication

Chapter 351-6 contains no age affirmation requirement. Under Rule 351-6-.07(3), product information may be provided directly to physicians via electronic communication, printed mail pieces, or in-person communication.

Location-based devices

Section 16-12-215 and Chapter 351-6 contain no location-based device provision.

Established customers

Section 16-12-215(b) prohibits advertising or marketing to registered patients, and states no exception for existing or opted-in patients.

People Depicted in Ads

Section 16-12-215 and Chapter 351-6 state no casting rule for advertising, and no minimum age for persons appearing in advertising. Consumer advertising is prohibited by §16-12-215(b).

For physician-directed material, Rule 351-6-.07(1) requires information to be accurate, truthful, and appropriately substantiated. For packaging, Rule 351-6-.06 permits only trademarks, licensed logos, or imagery previously approved by the Commission or the Executive Director.

Restricted Locations and Buffer Distances

Section 16-12-215(b) states no advertising buffer. The provision states no distance around any facility type. This is an absence in the statute rather than an omission from this page.

Licensing Buffers That Are Not Advertising Buffers

Under §16-12-215(a), no licensee shall operate in any location, whether for cultivation, harvesting, and processing of marijuana or for processing, manufacturing, packaging, or distributing low THC oil or products, within a 3,000 foot radius of a covered entity, measured from property boundary to property boundary. No dispensing licensee may operate within a 1,000 foot radius of a covered entity, measured the same way.

A covered entity means a public or private school, an early care and education program as defined in Code Section 20-1A-2, or a church, synagogue, or other place of public religious worship, in existence prior to the date of licensure. Local governments may, using existing zoning powers, allow dispensing licensees to locate elsewhere where needed to serve registered patients in that jurisdiction.

Both radii govern where a licensee may operate. Neither governs the placement of an advertisement.

A 2026 Amendment to Check

Senate Bill 220, signed in 2026, amends §16-12-215, including replacing references to low THC oil with medical cannabis and providing that on and after July 1, 2026 no dispensing licence shall be issued for any location where the retail sale of distilled spirits would be prohibited under Code Section 3-3-21(a)(1). The amendment also affects the structure surrounding the advertising subsection. Check the current statutory text before relying on this summary.

Can You Run a Digital Out of Home Screen in Georgia?

Section 16-12-215(b) prohibits advertising or marketing low THC oil or products to registered patients or the public. A screen advertising product to the public falls within that prohibition. The statute states no buffer, daypart or audience condition that would permit it.

Compliant Use of Geotargeting

• Section 16-12-215(b) states no advertising buffer, and permits no consumer placement to geotarget.
• Do not apply the 3,000 foot or 1,000 foot figures from §16-12-215(a) to media placement. Both are licensing radii measured property boundary to property boundary.
• For physician-directed communication, the control is the distribution method named in Rule 351-6-.07(3) rather than geography. Keep records of how material was distributed.
• Re-check §16-12-215 following Senate Bill 220 before planning anything in Georgia.

One advertising rule set. Georgia has no adult-use programme and no conventional medical marijuana programme. The low THC oil programme under the Hope Act permits registered patients to possess up to 20 fluid ounces of low THC oil, and permits licensees to produce and dispense it. Possession of any other form of marijuana remains unlawful under state and federal law.

The Georgia Department of Public Health maintains the Low THC Oil Registry and issues patient cards. The Georgia Access to Medical Cannabis Commission licenses production and dispensing. The State Board of Pharmacy has a role in dispensing. Physicians certify rather than prescribe: the law protects registered patients from prosecution rather than authorising prescription.

Senate Bill 220 in 2026 began replacing the statutory term low THC oil with medical cannabis.

Who regulates hemp here

The Georgia Department of Agriculture, under the Georgia Hemp Farming Act. This is a separate framework from the low THC oil programme and a different agency from the Commission.

Non-intoxicating hemp and CBD

Permitted through general retail. A hemp product within the federal and state hemp definitions is not low THC oil and is not sold by a Commission licensee, so §16-12-215(b) does not apply to it. General Georgia consumer protection law and federal restrictions on health claims apply instead.

Intoxicating hemp-derived cannabinoids

Georgia enacted Senate Bill 494 in 2024, setting a minimum purchase age of 21 and adding testing and labelling requirements and restrictions on certain products. The framework has continued to change through subsequent sessions. The federal definition of hemp narrows in November 2026. Confirm the current status before planning a hemp campaign.

What it means for advertising

Section 16-12-215(b) binds licensees under the low THC oil programme. A hemp product sold through general retail under the Department of Agriculture framework is not sold by a Commission licensee, so that prohibition does not apply to it. Classify each product before building a media plan.

Every statement on this page traces to one of the following:

• O.C.G.A. §16-12-215, Limitation on locations; advertising or marketing prohibited; information available to physicians
• GMCC Rules Chapter 351-6, including Rule 351-6-.07 Advertising and Marketing, Rule 351-6-.05 Dispensing License Operations, Rule 351-6-.06 Labeling and Exit Packaging, and Rule 351-6-.02 General Dispensing License Rules
• Senate Bill 220, 2026 signed legislation, amending §16-12-215
• Georgia Department of Public Health, Low THC Oil Registry
• Georgia Hemp Farming Act, and Senate Bill 494 of 2024, Georgia Department of Agriculture